Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2026-05-13 @ 3:40 AM
Study NCT ID:
NCT06078657
Status:
UNKNOWN
Last Update Posted:
2023-10-12
First Post:
2023-09-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization: